Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTNM
NRC
Add up to 3 more stocks
CTNM
Contineum Therapeutics, Inc.
-0.96%
$12.60-0.12Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$473.95M
52W Range
$8.60 - $17.79
NRC
NRC Health
-2.86%
$20.18-0.60Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$454.90M
52W Range
$11.01 - $23.68
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 79.97 |
| Forward P/E | N/A | 22.94 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.98 | 69.46 |
| P/S Ratio | N/A | 3.25 |
| P/FCF Ratio | N/A | 21.02 |
| EV/EBITDA | N/A | 23.18 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 56.3% |
| Operating Margin | 0.0% | 10.5% |
| Net Margin | 0.0% | 4.2% |
| ROE | -24.0% | 89.4% |
| ROA | -23.0% | 4.3% |
| ROIC | -27.2% | 8.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 37.17 | 0.65 |
| Quick Ratio | 37.17 | 0.65 |
| Debt/Equity | 0.03 | 13.75 |
| Interest Coverage | N/A | 4.74 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 2.9% |
| Payout Ratio | N/A | 237.7% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.